Bilirubin levels in newborns can drop surprisingly fast with treatment. Under intensive phototherapy, bilirubin typically falls about 0.8 to 0.9 mg/dL per hour during the first four hours, then settles to roughly 0.45 to 0.5 mg/dL per hour over the full course of treatment. Without any intervention, bilirubin in healthy full-term babies naturally peaks around day three to five of life and then gradually declines over one to two weeks as the liver matures enough to process it efficiently.
How fast your baby’s levels fall depends on what’s causing the jaundice, whether treatment is being used, and how premature the baby is. Here’s what to expect across different scenarios.
How Fast Phototherapy Works
Phototherapy (the “bili lights” you’ll see in the hospital) is the most common treatment for newborn jaundice, and it works quickly. The light changes bilirubin in the skin into a form the baby can excrete without needing the liver to process it first. Intensive phototherapy, which uses high-irradiance blue light, produces the fastest results.
In a study of 43 newborns receiving intensive phototherapy, bilirubin dropped at an average rate of 0.84 mg/dL per hour during the first four hours. That means a baby starting at 20 mg/dL could potentially be down to around 16.5 mg/dL just four hours later. After that initial rapid phase, the rate of decline slows to about 0.47 mg/dL per hour for the remainder of treatment. Over a full 20-hour session, studies show an overall bilirubin reduction of roughly 47%.
The type of light matters less than you might think. LED and compact fluorescent phototherapy units produce nearly identical results, with rates of 0.78 and 0.9 mg/dL per hour respectively in the first four hours. What matters more is the intensity of the light and how much skin is exposed to it. That’s why hospitals sometimes use multiple light sources at once or place babies on fiberoptic blankets in addition to overhead lights.
Fiberoptic Blankets for Home Use
Some babies with moderate jaundice go home with a fiberoptic phototherapy blanket. These wrap around the baby and deliver light directly to the skin. Research shows fiberoptic blankets reduce bilirubin at about 0.74% per hour, which is comparable to hospital blue-light units (0.84% per hour). They’re slower than intensive in-hospital setups, but effective enough for babies whose levels aren’t dangerously high.
When Phototherapy Stops
The American Academy of Pediatrics recommends stopping phototherapy once bilirubin has dropped at least 2 mg/dL below the threshold that triggered treatment in the first place. That threshold varies by the baby’s age in hours, gestational age, and whether any risk factors for bilirubin-related brain injury are present, such as prematurity, certain blood type incompatibilities, or G6PD deficiency.
One thing to watch for after the lights come off: bilirubin can bounce back slightly. This “rebound” is normal and usually small. In babies treated before hospital discharge, bilirubin rose an average of 1.3 mg/dL after phototherapy ended. Babies who were readmitted for treatment had even less rebound, averaging only 0.27 mg/dL. Rebound is measured between 4 and 48 hours after stopping treatment, and doctors typically schedule a follow-up bilirubin check during that window.
Babies born before 38 weeks, those younger than 48 hours when treatment started, or those with hemolytic disease (where red blood cells break down faster than normal) are more likely to rebound and may need a longer course of phototherapy before stopping.
Exchange Transfusion for Severe Cases
When bilirubin is dangerously high or climbing despite intensive phototherapy, exchange transfusion becomes necessary. This procedure replaces the baby’s blood in small amounts with donor blood, physically removing bilirubin from the circulation. It’s rare and reserved for the most serious cases.
A double-volume exchange transfusion removes about 59% of total bilirubin in a single procedure, which takes roughly 110 minutes. A single-volume exchange removes about 51% in approximately 99 minutes. The drop is dramatic and immediate, but bilirubin can reaccumulate afterward, so phototherapy typically continues following the procedure.
Why Some Babies Clear Bilirubin Slower
Bilirubin comes from the normal breakdown of red blood cells. Newborns produce more of it than adults because they have extra red blood cells from life in the womb, and those cells have shorter lifespans. The liver is responsible for converting bilirubin into a form the body can eliminate, but a newborn’s liver is still ramping up that ability.
Premature babies have an especially hard time. Their red blood cells break down even faster, their livers are more immature, and their gastrointestinal tracts are less efficient at eliminating bilirubin. Delayed feeding, which is common in premature infants, further slows things down because it reduces gut motility and the bacterial activity that helps clear bilirubin through stool. All of this means preterm babies tend to have higher peak levels, slower natural declines, and longer treatment courses than full-term babies.
Babies with hemolytic conditions, where something causes red blood cells to break down faster than normal (blood type incompatibility between mother and baby is the most common cause), also see bilirubin rise faster and take longer to come down. These babies often need more aggressive treatment and closer monitoring.
What a Typical Timeline Looks Like
For a healthy full-term baby with moderate jaundice who starts intensive phototherapy, a realistic timeline looks something like this: bilirubin drops noticeably within the first 4 to 6 hours, often by 3 to 4 mg/dL. Over 24 hours of continuous treatment, levels can fall by roughly half. If bilirubin drops at least 2 mg/dL below the treatment threshold, the lights come off and a follow-up check happens within the next day or two to make sure rebound stays minimal.
For babies whose jaundice resolves on its own without treatment, the timeline is much longer. Bilirubin peaks around day three to five, then slowly drifts down over one to two weeks. Breastfed babies sometimes have elevated bilirubin that persists for several weeks, which is generally harmless but can be alarming if you’re watching the numbers closely. The key difference is the rate: natural decline happens over days and weeks, while treatment-driven decline happens over hours.